Selected research
Industry Research
Histamine H4 Receptor Industry Research Report 2026
Market perspective
The global Histamine H4 Receptor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Histamine H4 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Histamine H4 Receptor is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Histamine H4 Receptor is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Histamine H4 Receptor include Johnson & Johnson, Ziarco Pharma Ltd, Sensorion S.A., Palau Pharma, S.A., OSE Pharma SA, Griffin Discoveries BV and Chrysalis Pharma SAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Histamine H4 Receptor market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Histamine H4 Receptor Market by Company
Johnson & Johnson
Ziarco Pharma Ltd
Sensorion S.A.
Palau Pharma, S.A.
OSE Pharma SA
Griffin Discoveries BV
Chrysalis Pharma SAS
Histamine H4 Receptor Segment by Type
GD-48
JNJ-28307474
UR-63325
ZPL-389
Others
Histamine H4 Receptor Segment by Application
Cystic Fibrosis
Atopic Dermatitis
Hearing Disorders
Asthma
Others
Histamine H4 Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histamine H4 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histamine H4 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histamine H4 Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Histamine H4 Receptor manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Histamine H4 Receptor by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Histamine H4 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GD-48
- JNJ-28307474
- UR-63325
- ZPL-389
- Others
Applications
- Cystic Fibrosis
- Atopic Dermatitis
- Hearing Disorders
- Asthma
- Others
Companies covered
- Johnson & Johnson
- Ziarco Pharma Ltd
- Sensorion S.A.
- Palau Pharma, S.A.
- OSE Pharma SA
- Griffin Discoveries BV
- Chrysalis Pharma SAS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Histamine H4 Receptor Market Size (2021-2032)
- 2.2.2 Global Histamine H4 Receptor Sales (2021-2032)
- 2.2.3 Global Histamine H4 Receptor Market Average Price (2021-2032)
- 2.3 Histamine H4 Receptor by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 GD-48
- 2.3.3 JNJ-28307474
- 2.3.4 UR-63325
- 2.3.5 ZPL-389
- 2.3.6 Others
- 2.4 Histamine H4 Receptor by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cystic Fibrosis
- 2.4.3 Atopic Dermatitis
- 2.4.4 Hearing Disorders
- 2.4.5 Asthma
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Histamine H4 Receptor Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Histamine H4 Receptor Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Histamine H4 Receptor Revenue of Manufacturers (2021-2026)
- 3.4 Global Histamine H4 Receptor Average Price by Manufacturers (2021-2026)
- 3.5 Global Histamine H4 Receptor Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Histamine H4 Receptor, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Histamine H4 Receptor, Product Type & Application
- 3.8 Global Manufacturers of Histamine H4 Receptor, Established Date
- 3.9 Global Histamine H4 Receptor Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Histamine H4 Receptor Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Ziarco Pharma Ltd
- 4.2.1 Ziarco Pharma Ltd Company Information
- 4.2.2 Ziarco Pharma Ltd Business Overview
- 4.2.3 Ziarco Pharma Ltd Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ziarco Pharma Ltd Histamine H4 Receptor Product Portfolio
- 4.2.5 Ziarco Pharma Ltd Recent Developments
- 4.3 Sensorion S.A.
- 4.3.1 Sensorion S.A. Company Information
- 4.3.2 Sensorion S.A. Business Overview
- 4.3.3 Sensorion S.A. Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sensorion S.A. Histamine H4 Receptor Product Portfolio
- 4.3.5 Sensorion S.A. Recent Developments
- 4.4 Palau Pharma, S.A.
- 4.4.1 Palau Pharma, S.A. Company Information
- 4.4.2 Palau Pharma, S.A. Business Overview
- 4.4.3 Palau Pharma, S.A. Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Palau Pharma, S.A. Histamine H4 Receptor Product Portfolio
- 4.4.5 Palau Pharma, S.A. Recent Developments
- 4.5 OSE Pharma SA
- 4.5.1 OSE Pharma SA Company Information
- 4.5.2 OSE Pharma SA Business Overview
- 4.5.3 OSE Pharma SA Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 OSE Pharma SA Histamine H4 Receptor Product Portfolio
- 4.5.5 OSE Pharma SA Recent Developments
- 4.6 Griffin Discoveries BV
- 4.6.1 Griffin Discoveries BV Company Information
- 4.6.2 Griffin Discoveries BV Business Overview
- 4.6.3 Griffin Discoveries BV Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Griffin Discoveries BV Histamine H4 Receptor Product Portfolio
- 4.6.5 Griffin Discoveries BV Recent Developments
- 4.7 Chrysalis Pharma SAS
- 4.7.1 Chrysalis Pharma SAS Company Information
- 4.7.2 Chrysalis Pharma SAS Business Overview
- 4.7.3 Chrysalis Pharma SAS Histamine H4 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chrysalis Pharma SAS Histamine H4 Receptor Product Portfolio
- 4.7.5 Chrysalis Pharma SAS Recent Developments
5 Global Histamine H4 Receptor Market Scenario by Region
- 5.1 Global Histamine H4 Receptor Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Histamine H4 Receptor Sales by Region: 2021-2032
- 5.2.1 Global Histamine H4 Receptor Sales by Region: 2021-2026
- 5.2.2 Global Histamine H4 Receptor Sales by Region: 2027-2032
- 5.3 Global Histamine H4 Receptor Revenue by Region: 2021-2032
- 5.3.1 Global Histamine H4 Receptor Revenue by Region: 2021-2026
- 5.3.2 Global Histamine H4 Receptor Revenue by Region: 2027-2032
- 5.4 North America Histamine H4 Receptor Market Facts & Figures by Country
- 5.4.1 North America Histamine H4 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Histamine H4 Receptor Sales by Country (2021-2032)
- 5.4.3 North America Histamine H4 Receptor Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Histamine H4 Receptor Market Facts & Figures by Country
- 5.5.1 Europe Histamine H4 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Histamine H4 Receptor Sales by Country (2021-2032)
- 5.5.3 Europe Histamine H4 Receptor Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Histamine H4 Receptor Market Facts & Figures by Country
- 5.6.1 Asia Pacific Histamine H4 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Histamine H4 Receptor Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Histamine H4 Receptor Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Histamine H4 Receptor Market Facts & Figures by Country
- 5.7.1 South America Histamine H4 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Histamine H4 Receptor Sales by Country (2021-2032)
- 5.7.3 South America Histamine H4 Receptor Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Histamine H4 Receptor Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Histamine H4 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Histamine H4 Receptor Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Histamine H4 Receptor Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Histamine H4 Receptor Sales by Type (2021-2032)
- 6.1.1 Global Histamine H4 Receptor Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Histamine H4 Receptor Sales Market Share by Type (2021-2032)
- 6.2 Global Histamine H4 Receptor Revenue by Type (2021-2032)
- 6.2.1 Global Histamine H4 Receptor Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Histamine H4 Receptor Revenue Market Share by Type (2021-2032)
- 6.3 Global Histamine H4 Receptor Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Histamine H4 Receptor Sales by Application (2021-2032)
- 7.1.1 Global Histamine H4 Receptor Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Histamine H4 Receptor Sales Market Share by Application (2021-2032)
- 7.2 Global Histamine H4 Receptor Revenue by Application (2021-2032)
- 7.2.1 Global Histamine H4 Receptor Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Histamine H4 Receptor Revenue Market Share by Application (2021-2032)
- 7.3 Global Histamine H4 Receptor Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Histamine H4 Receptor Value Chain Analysis
- 8.1.1 Histamine H4 Receptor Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Histamine H4 Receptor Production Mode & Process
- 8.2 Histamine H4 Receptor Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Histamine H4 Receptor Distributors
- 8.2.3 Histamine H4 Receptor Customers
9 Global Histamine H4 Receptor Analyzing Market Dynamics
- 9.1 Histamine H4 Receptor Industry Trends
- 9.2 Histamine H4 Receptor Industry Drivers
- 9.3 Histamine H4 Receptor Industry Opportunities and Challenges
- 9.4 Histamine H4 Receptor Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst